September 7th, 2009
On December 4, 2008, a top level FDA official said GlaxoSmithKline PLC's diabetes drug Avandia should remain available to patients despite some medical associations' calls for doctors not to use it.
Janet Woodcock, head of the FDA's Center for Drug Evaluation and Research, said in an interview that people have "convicted" ...
Posted in Legal News | Comments Off
September 7th, 2009
Based upon information from a new study released on December 10, 2008, long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes.
Scientists previously knew the two thiazolidinedione (TZD) drugs for diabetes were associated with fractures, but the magnitude of the ...
Posted in Legal News | Comments Off
September 7th, 2009
On December 17, 2008, the FDA announced that new drugs to treat an epidemic of diabetes will have to be screened more closely for heart risks. The FDA’s policy change should offer a greater assurance of safety to doctors and patients. But it will make it more costly and time-consuming ...
Posted in Legal News | Comments Off
September 7th, 2009
Diabetes drugs called glitazones, which include Avandia, and Actos have been associated with an increased risk of a vision-threatening complication called diabetic macular edema (DME), which features swelling and fluid accumulation in the retina.
The U.S. study of 996 diabetic macular edema (DME) patients found that those who took glitazones were ...
Posted in Legal News | Comments Off
September 7th, 2009
On April 30, 2009, ten residents of Utah and two people from Oregon filed federal lawsuits against GlaxoSmithKline PLC claiming that the company was negligent in researching the drug Avandia, which caused them (or a spouse) to have heart attacks and subsequent health problems.
The lawsuits state the firm deceived doctors ...
Posted in Legal News | Comments Off
September 7th, 2009
The FDA recently announced that the agency is primed to finalize long-awaited sunscreen label changes designed to give consumers a better idea of the sun protection they’re getting.
Companies that make sunscreens will now be required to provide information on the amount of ultraviolet A (UVA) screening provided by their products. ...
Posted in Legal News | Comments Off
September 7th, 2009
As the U.S. chemical industry steps up its fierce lobbying effort, the California Senate approved a proposal on June 2, 2009, that would ban the use of bisphenol A (BPA) in baby bottles, toddler sippy cups and food containers that independent scientists say is a threat to childhood development.
The bill ...
Posted in Legal News | Comments Off
September 7th, 2009
A New Jersey oncologist whom health officials believe was responsible for a hepatitis B outbreak earlier this year was sued by one of his patients last month. The patient’s lawsuit claims he contracted the disease after being treated for prostate cancer at the offices of Dr. Parvez Dara, most recently ...
Posted in Legal News | Comments Off
September 7th, 2009
A recently released clinical study intended to test whether GlaxoSmithKline PLC's diabetes drug Avandia may be harmful to the heart appears to have raised more questions than it has answered, as some doctors claim that the study is flawed.
Safety concerns have troubled Avandia since 2007, when an analysis of the ...
Posted in Legal News | Comments Off
September 7th, 2009
Canadian researchers, on August 18, 2009, stated that the type 2 diabetes drug Avandia (generic: rosiglitazone) increases the risk of heart failure and death more than Actos (generic: (pioglitazone), another drug in the same class. As far back as 2008, Avandia has been the subject of controversy, when it was ...
Posted in Legal News | Comments Off
